New developments in antibody therapy for acute myeloid leukemia

被引：15

作者：

Tomblyn, MR ^{[1
]}

Tallman, MS ^{[1
]}

机构：

[1] Northwestern Univ, Feinberg Sch Med, Div Hematol Oncol, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA

来源：

SEMINARS IN ONCOLOGY | 2003年 / 30卷 / 04期

关键词：

D O I：

10.1016/S0093-7754(03)00234-3

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：502 / 508

页数：7

共 42 条

[1]

Alvarez RH, 2002, BLOOD, V100, p340A

[2]

Amadori S, 2002, BLOOD, V100, p340A

[3]

Appelbaum F R, 2001, Hematology Am Soc Hematol Educ Program, P62

[4]

Baccarani M, 2002, BLOOD, V100, p341A

[5] VENOOCCLUSIVE DISEASE OF THE LIVER - DEVELOPMENT OF A MODEL FOR PREDICTING FATAL OUTCOME AFTER MARROW TRANSPLANTATION [J].

BEARMAN, SI ;

ANDERSON, GL ;

MORI, M ;

HINDS, MS ;

SHULMAN, HM ;

MCDONALD, GB .

JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (09) :1729-1736

[6]

Bross PF, 2001, CLIN CANCER RES, V7, P1490

[7]

Castaigne S, 2002, BLOOD, V100, p767A

[8] Gemtuzumab ozogamicin (Mylotarg) monotherapy for relapsed AML after hematopoietic stem cell transplant: efficacy and incidence of hepatic veno-occlusive disease [J].

Cohen, AD ;

Luger, SM ;

Sickles, C ;

Mangan, PA ;

Porter, DL ;

Schuster, SJ ;

Tsai, DE ;

Nasta, S ;

Gewirtz, AM ;

Stadtmauer, EA .

BONE MARROW TRANSPLANTATION, 2002, 30 (01) :23-28

[9] Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotype [J].

Cuneo, A ;

Bigoni, R ;

Cavazzini, F ;

Bardi, A ;

Roberti, MG ;

Agostini, P ;

Tammiso, E ;

Ciccone, N ;

Mancini, M ;

Nanni, M ;

De Cuia, R ;

Divona, M ;

La Starza, R ;

Crescenzi, B ;

Testoni, N ;

Cambrin, GR ;

Mecucci, C ;

Lo Coco, F ;

Saglio, G ;

Castoldi, G .

LEUKEMIA, 2002, 16 (09) :1745-1751

[10]

De Angelo DJ, 2002, BLOOD, V100, p198A

← 1 2 3 4 5 →